Start AVONEX today for a better tomorrow

Treating MS is an ongoing commitment that can help you stay active, so it’s important to find an effective therapy you can live with over the long term. If you’ve recently been diagnosed with MS, you and your physician may have already discussed your options, and the importance of getting started on a therapy as soon as possible.

AVONEX reduced physical disability progression in a 10-year study

CHAMPIONS was a 10-year follow-up of a 3-year study; making it the longest continuous analysis of people who began treatment in early MS.

AVONEX slowed disability by 37% in a 2-year study
FDA-approved labeling includes up to 3 years of clinical data

Early AVONEX treatment reduces the risk of a second flare-up

Flare-ups can make simple tasks more difficult and generally disrupt your life. AVONEX reduces the number of flare-ups, so you can get on with your life.

In the first 3 years, the risk of a second flare-up was reduced by 44% when patients started AVONEX within 30 days of a first flare-up (compared with patients who delayed AVONEX treatment approximately 2.5 years).

Early treatment with AVONEX continued to reduce the risk of a second flare-up by 40% for the full 10 years of the study as compared to those who delayed treatment.

Over the 10 years, patients who began early AVONEX treatment averaged 1 flare-up every 6 years compared to an average of 1 flare-up every 3 years for those who delayed treatment. This includes all patients at 10 years regardless of whether they were still taking AVONEX.

It’s never too late to begin treatment

If you have relapsing MS, starting treatment right away may give you the best chance for reducing flare-ups now, as well as slowing the progression of physical disability in the future.

But not everyone is able to begin therapy immediately after a first flare-up. If you’re not currently being treated for MS, you can still reduce your risk of flare-ups and physical disability progression if you start therapy right now.

10 years later — the bottom line

80% of AVONEX patients remained active and able
Almost 60% of patients were still choosing to stay on AVONEX
Patients who began AVONEX treatment within 30 days of their first flare-up were 40% less likely to have a second flare-up over 10 years compared with those who delayed treatment